To study the effect of bepotastine besilate (bepotastine) on skin barrier function, we induced dermatitis on the back of C57BL/6 mice by tape stripping with or without oral administration of bepotastine, and investigated the mRNA expression levels of molecules associated with skin barrier function and inflammatory cytokines by real-time RT-PCR. Dermatitis was much milder in mice treated with bepotastine than vehicle-treated mice, and involucrin expression in the former mice was significantly higher than that in the latter mice (p<0.05). Filaggrin expression also tended to be increased by bepotastine treatment. With regard to cytokine expression, bepotastine significantly decreased IL-6 expression (p<0.05). Expression levels of IL-1β, IL-23p19, and IL-17A also tended to be decreased by bepotastine, although the differences were not statistically significant. Our study has suggested that bepotastine not only improves pruritus, but also inhibits expression of inflammatory cytokines, suggesting potential for its improvement of skin barrier function.Skin Research, 14: 391-396, 2015
View full abstract